227 related articles for article (PubMed ID: 25141830)
1. The importance of proximity to death in modelling community medication expenditures for older people: evidence from New Zealand.
Moore PV; Bennett K; Normand C
Appl Health Econ Health Policy; 2014 Dec; 12(6):623-33. PubMed ID: 25141830
[TBL] [Abstract][Full Text] [Related]
2. Health system costs by sex, age and proximity to death, and implications for estimation of future expenditure.
Blakely T; Atkinson J; Kvizhinadze G; Nghiem N; McLeod H; Wilson N
N Z Med J; 2014 May; 127(1393):12-25. PubMed ID: 24816953
[TBL] [Abstract][Full Text] [Related]
3. Counting the time lived, the time left or illness? Age, proximity to death, morbidity and prescribing expenditures.
Moore PV; Bennett K; Normand C
Soc Sci Med; 2017 Jul; 184():1-14. PubMed ID: 28482276
[TBL] [Abstract][Full Text] [Related]
4. The impact of population ageing on future Danish drug expenditure.
Kildemoes HW; Christiansen T; Gyrd-Hansen D; Kristiansen IS; Andersen M
Health Policy; 2006 Feb; 75(3):298-311. PubMed ID: 16399170
[TBL] [Abstract][Full Text] [Related]
5. Time to death and health expenditure: an improved model for the impact of demographic change on health care costs.
Seshamani M; Gray A
Age Ageing; 2004 Nov; 33(6):556-61. PubMed ID: 15308460
[TBL] [Abstract][Full Text] [Related]
6. The adoption of pharmaceutical innovation and its impact on the treatment costs for Alzheimer's disease in Taiwan.
Lo TF; Hsieh CR
J Ment Health Policy Econ; 2014 Sep; 17(3):107-17. PubMed ID: 25543114
[TBL] [Abstract][Full Text] [Related]
7. Life expectancy and health care expenditures: a new calculation for Germany using the costs of dying.
Breyer F; Felder S
Health Policy; 2006 Jan; 75(2):178-86. PubMed ID: 15893848
[TBL] [Abstract][Full Text] [Related]
8. Updated New Zealand health system cost estimates from health events by sex, age and proximity to death: further improvements in the age of 'big data'.
Blakely T; Atkinson J; Kvizhinadze G; Nghiem N; McLeod H; Davies A; Wilson N
N Z Med J; 2015 Sep; 128(1422):13-23. PubMed ID: 26411843
[TBL] [Abstract][Full Text] [Related]
9. The effect of lengthening life expectancy on future pension and long-term care expenditure in England, 2007 to 2032.
Malley J; Hancock R; Murphy M; Adams J; Wittenberg R; Comas-Herrera A; Curry C; King D; James S; Morciano M; Pickard L
Health Stat Q; 2011; (52):33-61. PubMed ID: 22143594
[TBL] [Abstract][Full Text] [Related]
10. Spending on medicines in Israel in an international context.
Sax P
Isr Med Assoc J; 2005 May; 7(5):286-91. PubMed ID: 15909459
[TBL] [Abstract][Full Text] [Related]
11. The effect of longevity on spending for acute and long-term care.
Spillman BC; Lubitz J
N Engl J Med; 2000 May; 342(19):1409-15. PubMed ID: 10805827
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical expenditures as a correlate of population health in industrialized nations.
Liu L; Cline RR; Schondelmeyer SW; Schommer JC
Ann Pharmacother; 2008 Mar; 42(3):368-74. PubMed ID: 18272699
[TBL] [Abstract][Full Text] [Related]
13. Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
Rothbard AB; Lee S; Blank MB
J Ment Health Policy Econ; 2009 Dec; 12(4):187-94. PubMed ID: 20195006
[TBL] [Abstract][Full Text] [Related]
14. Health care costs in the last year of life--the Dutch experience.
Polder JJ; Barendregt JJ; van Oers H
Soc Sci Med; 2006 Oct; 63(7):1720-31. PubMed ID: 16781037
[TBL] [Abstract][Full Text] [Related]
15. Physician and patient characteristics associated with prescriptions and costs of drugs in the Lazio region of Italy.
Orzella L; Chini F; Giorgi Rossi P; Borgia P
Health Policy; 2010 May; 95(2-3):236-44. PubMed ID: 20047773
[TBL] [Abstract][Full Text] [Related]
16. Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada.
Hanley GE; Morgan S
Soc Sci Med; 2009 Mar; 68(5):919-24. PubMed ID: 19135288
[TBL] [Abstract][Full Text] [Related]
17. Temporal trends in the relative cost of dying: evidence from Canada.
Payne G; Laporte A; Foot DK; Coyte PC
Health Policy; 2009 May; 90(2-3):270-6. PubMed ID: 19041152
[TBL] [Abstract][Full Text] [Related]
18. Short-term persistence of high health care costs in a nationally representative sample of children.
Liptak GS; Shone LP; Auinger P; Dick AW; Ryan SA; Szilagyi PG
Pediatrics; 2006 Oct; 118(4):e1001-9. PubMed ID: 17015496
[TBL] [Abstract][Full Text] [Related]
19. No short-term savings in health care expenditures for physically active adults.
Chevan J; Roberts DE
Prev Med; 2014 Jun; 63():1-5. PubMed ID: 24607364
[TBL] [Abstract][Full Text] [Related]
20. Trends in health care expenditures, utilization, and health status among US adults with spine problems, 1997-2006.
Martin BI; Turner JA; Mirza SK; Lee MJ; Comstock BA; Deyo RA
Spine (Phila Pa 1976); 2009 Sep; 34(19):2077-84. PubMed ID: 19675510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
